Gunnar Bockelmann

Financial toxicity in cancer patients treated with radiotherapy in Germany—a cross-sectional study

A. Grosu, N. Nicolay, J. Dunst, 2022, Strahlentherapie und Onkologie.

Financial toxicity in cancer patients treated with radiotherapy in Germany—a cross-sectional study

A. Grosu, N. Nicolay, J. Dunst, 2022, Strahlentherapie und Onkologie.

Adjuvant HDR-Brachytherapy for Treatment of Recurrent Keloids

D. Druecke, P. Niehoff, J. Dunst, 2013 .

The 15-year outcomes of high-dose-rate brachytherapy for radical dose escalation in patients with prostate cancer - a benchmark for high-tech external beam radiotherapy alone?

R. Galalae, B. Kimmig, F. Geiger, 2014, Brachytherapy.

Radical dose escalation by high-dose-rate brachytherapy for localized prostate cancer-Significance of prostate-specific antigen nadir level within 18 months as correlation for long-term biochemical control.

R. Galalae, B. Kimmig, J. Dunst, 2019, Brachytherapy.